174 related articles for article (PubMed ID: 31577977)
1. Novel tertiary sulfonamide derivatives containing benzimidazole moiety as potent anti-gastric cancer agents: Design, synthesis and SAR studies.
Jian-Song ; Gao QL; Wu BW; Li D; Shi L; Zhu T; Lou JF; Jin CY; Zhang YB; Zhang SY; Liu HM
Eur J Med Chem; 2019 Dec; 183():111731. PubMed ID: 31577977
[TBL] [Abstract][Full Text] [Related]
2. Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway.
Song J; Gao QL; Wu BW; Zhu T; Cui XX; Jin CJ; Wang SY; Wang SH; Fu DJ; Liu HM; Zhang SY; Zhang YB; Li YC
Eur J Med Chem; 2020 Oct; 203():112618. PubMed ID: 32682200
[TBL] [Abstract][Full Text] [Related]
3. Discovery of
Niu JB; Hua CQ; Liu Y; Yu GX; Yang JJ; Li YR; Zhang YB; Qi YQ; Song J; Jin CY; Zhang SY
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1715-1731. PubMed ID: 34425716
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers.
Song J; Liu Y; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Fu XJ; Zhang SY
Eur J Med Chem; 2021 Dec; 225():113801. PubMed ID: 34455358
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties.
Zhao JW; Wu ZH; Guo JW; Huang MJ; You YZ; Liu HM; Huang LH
Eur J Med Chem; 2019 Nov; 181():111520. PubMed ID: 31404863
[TBL] [Abstract][Full Text] [Related]
6. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5-
Yu GX; Hu Y; Zhang WX; Tian XY; Zhang SY; Zhang Y; Yuan S; Song J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956943
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
[TBL] [Abstract][Full Text] [Related]
9. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel (S)-tryptamine derivatives containing an allyl group and an aryl sulfonamide unit as anticancer agents.
Guo Z; Xu Y; Peng Y; Haroon Ur Rashid ; Quan W; Xie P; Wu L; Jiang J; Wang L; Liu X
Bioorg Med Chem Lett; 2019 May; 29(9):1133-1137. PubMed ID: 30842032
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors.
Wang YT; Shi TQ; Zhu HL; Liu CH
Bioorg Med Chem; 2019 Feb; 27(3):502-515. PubMed ID: 30606674
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS
Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators.
Li R; Ning X; He J; Lin Z; Su Y; Li R; Yin Y
Bioorg Chem; 2021 Mar; 108():104653. PubMed ID: 33517002
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.
Liang Z; Lei F; Deng J; Zhang H; Wang Y; Li J; Shi T; Yang X; Wang Z
Eur J Med Chem; 2022 Jan; 228():113960. PubMed ID: 34774339
[TBL] [Abstract][Full Text] [Related]
19. Novel benzimidazole derivatives: Synthesis, in vitro cytotoxicity, apoptosis and cell cycle studies.
Atmaca H; İlhan S; Batır MB; Pulat ÇÇ; Güner A; Bektaş H
Chem Biol Interact; 2020 Aug; 327():109163. PubMed ID: 32534988
[TBL] [Abstract][Full Text] [Related]
20. Discovery of the theobromine derivative MQS-14 that induces death of MGC-803 cells mainly through ROS-mediated mechanisms.
Ma T; Ma QS; Yu B; Liu HM
Eur J Med Chem; 2019 Jul; 174():76-86. PubMed ID: 31029946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]